Skip to main content

. 1954 Jul 24;2(4881):197–199. doi: 10.1136/bmj.2.4881.197

The Control of Anticoagulant Therapy in Myocardial Infarction

R B Hunter, W Walker

PMCID: PMC2079366 PMID: 13172502

199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Alexander B., de Vries A., Goldstein R., Landwehr G. A Prothrombin Conversion Accelerator in Serum. Science. 1949 May 27;109(2839):545–545. doi: 10.1126/science.109.2839.545. [DOI] [PubMed] [Google Scholar]
BIGGS R., DOUGLAS A. S. The measurement of prothrombin in plasma; a case of prothrombin deficiency. J Clin Pathol. 1953 Feb;6(1):15–22. doi: 10.1136/jcp.6.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
HUNTER R. B., TUDHOPE G. R. Mode of action of tromexan. Lancet. 1953 Apr 25;1(6765):821–823. doi: 10.1016/s0140-6736(53)91951-5. [DOI] [PubMed] [Google Scholar]
LOUDON I. S. L., PEASE J. C., COOKE A. M. Anticoagulants in myocardial infarction. Br Med J. 1953 Apr 25;1(4816):911–913. doi: 10.1136/bmj.1.4816.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
STIRLING M., HUNTER R. B. Pharmacology of bis 3-3'-(4 oxycoumarinyl) ethyl acetate (tromexan). Lancet. 1951 Oct 6;2(6684):611–614. doi: 10.1016/s0140-6736(51)92888-7. [DOI] [PubMed] [Google Scholar]
TULLOCH J. A., GILCHRIST A. R. Anticoagulants in treatment of coronary thrombosis. Br Med J. 1950 Oct 28;2(4686):965–971. doi: 10.1136/bmj.2.4686.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
WRIGHT H. P., KUBIK M. M., HAYDEN M. Recanalization of thrombosed arteries under anticoagulant therapy. Br Med J. 1953 May 9;1(4818):1021–1023. doi: 10.1136/bmj.1.4818.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES